title: HIV expression levels ex vivo: a surrogate marker for clinical endpoints in the evaluation of AIDS treatments?
authors.affiliation: Hôpital Raymond-Poincaré, Garches, France.
authors.forename: D
authors.initials: D
authors.lastname: Mathez
authors.forename: D
authors.initials: D
authors.lastname: Paul
authors.forename: C
authors.initials: C
authors.lastname: Bélilovsky
authors.forename: Y
authors.initials: Y
authors.lastname: Sultan
authors.forename: I
authors.initials: I
authors.lastname: Gorin
authors.forename: J
authors.initials: J
authors.lastname: Deleuze
authors.forename: W
authors.initials: W
authors.lastname: Saurin
authors.forename: R
authors.initials: R
authors.lastname: Decker
authors.forename: J
authors.initials: J
authors.lastname: Leibowitch
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000382:microbiology; D000998:Antiviral Agents / Q000627:therapeutic use; D002478:Cells, Cultured; D006678:HIV / Q000235:genetics / Q000502:physiology*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000382:microbiology*; D014779:Virus Replication
chemical_list: D000998:Antiviral Agents